Building Global Antibiotic Resistance Monitoring Capacities
Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Segment Description: Dr. Pol Vandenbroucke, Chief Medical Officer for Pfizer’s hospital business unit, describes efforts to build up capacity for antimicrobial resistance surveillance in low- and middle-income countries. Dr. Vandenbroucke also explains how the development of both health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Recent Videos
Related Content
